首页> 外国专利> HUMAN INTERFERON-.BETA.2A AND INTERFERON-.BETA.2B; VECTORS CONTAINING GENES CODING FOR SAID INTERFERONS: CELL LINES PRODUCING SAME AND USE OF SAID INTERFERONS AS PHARMACEUTICALS

HUMAN INTERFERON-.BETA.2A AND INTERFERON-.BETA.2B; VECTORS CONTAINING GENES CODING FOR SAID INTERFERONS: CELL LINES PRODUCING SAME AND USE OF SAID INTERFERONS AS PHARMACEUTICALS

机译:人干扰素-.BETA.2A和干扰素-.BETA.2B;含有针对所述干扰素的基因编码的矢量:生产相同干扰素的细胞系以及将所述干扰素用作药物

摘要

Human interferon-beta2A and interferon-beta2B are produced in purifiedform by recombinant DNA techniques. Two separate human genes havebeen identified which code for the production of IFN-.beta.2A and IFN-.beta.2B,respectively. The sequence of IFN-.beta.2A cDNA is established. Thesegenes and cDNA have been cloned into mammlian cells with an SV40early promoter sequence and such genomic clones are capable of pro-ducing IFN-.beta.2A and IFN-.beta.2B. The antaviral activity of suchrecombinant IFN-.beta.2A and IFN-.beta.2B is demonstrated as well as otherbiological activity identifying them as human interferons. It has beenshown that IFN-.beta.2 secretion is induced in human cells by growth-stimulatory cytokines.
机译:人干扰素-β2A和干扰素-β2B纯化通过重组DNA技术形成。两个独立的人类基因具有鉴定出产生IFN-β.2A和IFN-的代码β.2B,分别。建立了IFN-β2AcDNA的序列。这些SV40基因和cDNA已克隆到哺乳动物细胞中早期启动子序列和此类基因组克隆能够产生IFN-β2A和IFN-β2B。此类的抗昆虫活性重组IFN-β2A和IFN-β2B以及其他生物活性,将其鉴定为人类干扰素。它一直研究表明,人细胞中的IFN-β2分泌是通过生长-刺激性细胞因子。

著录项

  • 公开/公告号CA1341369C

    专利类型

  • 公开/公告日2002-06-18

    原文格式PDF

  • 申请/专利权人 REVEL MICHEL;ZILBERSTEIN ASHER;

    申请/专利号CA19860520275

  • 发明设计人 REVEL MICHEL;ZILBERSTEIN ASHER;

    申请日1986-10-10

  • 分类号C12N15/20;A61K38/16;A61K38/21;

  • 国家 CA

  • 入库时间 2022-08-22 00:41:22

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号